Jazz Pharmaceuticals (JAZZ): Officer sold ~$379K
Mary Elizabeth Henderson, Officer at Jazz Pharmaceuticals, sold ~$379K of Jazz Pharmaceuticals shares.
- ~$379K
- Approx. value · 2,238 sh @ $169.51
- 20K
- Holds after · shares reported
- Traded
- Dec 9, 2025
- Filed
- Dec 12, 2025
What stands out in this filing
- The sale was 10.3% of the shares this insider held before it; the filing reports 19,508 shares afterwards.
- 2,238 shares at an average of $169.51 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 34 days earlier (Nov 5, 2025). The first one after it: reported its results, 34 days later (Jan 12, 2026).
- Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 23, 2025, the board of directors (the “Board”) of Jazz Pharmaceuticals plc (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Ted Love to the Board, effective as of December 1, 2025, as a Class I director for a term expiring at the annual general meeting of shareholders to be held in 2027.”
- Company filing · Form 8-K · ResultsReported its results
- Insider · Their largest sale since 2022Officer sold ~$1.2M of JAZZ shares in the open market
- Insider · 3 peopleInsiders: 7 sales (~$5.2M)
- InsiderDirector sold ~$607K of JAZZ shares in the open market
- Insider · 1 personInsiders: 4 sales (~$13.8M)
- Insider · 1 personInsiders: 2 sales (~$798K)
- InsiderOfficer sold ~$379K of JAZZ shares in the open market
What came next
- Company filing · Form 8-K · ResultsReported its results
- Company filing · Form 8-K · ResultsReported its results
- Insider · 3 peopleInsiders: 13 sales (~$11.9M)
- Insider · 2 peopleInsiders: 2 sales (~$869K)
- Insider · 1 personInsiders: 3 sales (~$1.1M)
- InsiderOfficer sold ~$235K of JAZZ shares in the open market
- Insider · 1 personInsiders: 3 sales (~$1.1M)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Jazz Pharmaceuticals
For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JAZZ page.
Other recent filings by Mary Elizabeth Henderson, SVP, Technical Operations
The full history of Mary Elizabeth Henderson, SVP, Technical Operations is on the profile page.
How this filing works
Explore the data
Common questions
Which Jazz Pharmaceuticals (JAZZ) insider traded, and how much?
Mary Elizabeth Henderson, Officer at Jazz Pharmaceuticals, sold ~$379K of Jazz Pharmaceuticals shares. 2,238 shares at $169.51.
When did it happen, and when was it made public?
Traded: Dec 9, 2025. Filed: Dec 12, 2025. That is 3 days between the two dates.
What stands out in this filing?
The sale was 10.3% of the shares this insider held before it; the filing reports 19,508 shares afterwards. 2,238 shares at an average of $169.51 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Jazz Pharmaceuticals recently?
For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the JAZZ page.
Does this mean JAZZ stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Jazz Pharmaceuticals
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 6, 2026
- SEC Form 4Nov 6, 2026
Everything OQRO holds on this company is on its JAZZ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
